MétaCan
Menu
Back to cohort
Record W270032659

"Traditional Use" and Regulatory Change in the Arena of Natural Health Products

2007· article· en· W270032659 on OpenAlexvenueaboutno aff
Vincent Kurata

Bibliographic record

VenueHealth law review · 2007
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsnot available
Fundersnot available
KeywordsGovernment (linguistics)Product (mathematics)BusinessHealth claims on food labelsAdvertisingConsumer protectionLawPolitical scienceCommerce
DOInot available

Abstract

fetched live from OpenAlex

Over the last three years, the federal government has been pressured to loosen advertising restrictions on Natural Health Products (NHPs). Such pressure has originated both externally (consumer petitions and the industry lobby) and internally (private member's bills). Government responded to this pressure by proposing new NHP regulations that would see these products exempted from the claim effected by s. 3 of the Food and Drugs Act (FDA). The health claim prohibition has functioned, in the past, to prevent NHP manufacturers from advertising their goods as treatments, cures or preventatives for a list of approximately 40 serious diseases / conditions set out in the FDA. With respect to diseases not covered by the health claim prohibition, NHP manufacturers have been allowed to advertise their goods as cures, treatments or preventatives provided that they could prove the safety and efficacy of the product with scientific data. The use has functioned as a regulatory loophole of sorts, allowing NHP manufacturers to advertise their goods as treatments, cures or preventatives for ailments excepted from the health claim prohibition, provided that they could demonstrate that the NHP has been traditionally as a treatment, cure or preventative for the ailment in question. The exception has been harshly criticized by groups such as the Centre for Science in the Public Interest because it has allowed NHP manufacturers to make health claims respecting NHPs even when the effectiveness of the product has been disproved scientifically. Moreover, Health Canada has proposed a regulatory amendment that will completely exempt NHPs from the health claim prohibition, thus expanding the scope of application attendant to the traditional use exception. This presentation discussed the legal nuances of the traditional use exception from a critical perspective, and advanced arguments opposing prospective regulatory changes that would provide NHP manufacturers greater leeway in advertising. These arguments were threefold. First, allowing health claims based only on traditional use is an invitation for charlatanry. Consumers rely on health claims when purchasing NHPs, and leaving them unregulated will result in economic exploitation. David Schardt has highlighted many ridiculous health claims in his article, Herbal Roulette: Does it work? Is it safe? Don't ask the government. (1) For example, Schardt notes that Echinacea has been shown in a number of scientific studies to be ineffective in the prevention of colds. Nonetheless, he asserts, Health Canada's Natural Health Products Directorate allows manufacturers to label Echinacea as being traditionally used to fight off colds, flus and infections. …

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.811
Threshold uncertainty score0.787

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0080.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.743
GPT teacher head0.599
Teacher spread0.143 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2007
Admission routes2
Has abstractyes

Explore more

Same venueHealth law reviewSame topicPharmaceutical industry and healthcareFrench-language works237,207